Cite
HARVARD Citation
Fukuda, K. et al. (2020). Glycogen synthase kinase‐3 inhibition overcomes epithelial‐mesenchymal transition‐associated resistance to osimertinib in EGFR‐mutant lung cancer. Cancer science. 111 (7), pp. 2374-2384. [Online].